A E Tattersfield
Overview
Explore the profile of A E Tattersfield including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
185
Citations
3047
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Harknett E, Chang W, Byrnes S, Johnson J, Lazor R, COHEN M, et al.
QJM
. 2011 Jul;
104(11):971-9.
PMID: 21764810
Background: Understanding the true prevalence of lymphangioleiomyomatosis (LAM) is important in estimating disease burden and targeting specific interventions. As with all rare diseases, obtaining reliable epidemiological data is difficult and...
2.
3.
Mortimer K, Tata L, Smith C, West J, Harrison T, Tattersfield A, et al.
Thorax
. 2006 Mar;
61(5):405-8.
PMID: 16517576
Background: Adrenal insufficiency, a well recognised complication of treatment with oral corticosteroids, has been described in association with inhaled corticosteroid use in over 60 case reports. The risk of adrenal...
4.
5.
Mortimer K, Harrison T, Tattersfield A
Ann Allergy Asthma Immunol
. 2005 Feb;
94(1):15-21.
PMID: 15702810
Objective: To discuss the effects of inhaled corticosteroids on bone and their potential public health implications. Data Sources: The MEDLINE and EMBASE databases were searched to identify articles published between...
6.
Cushley M, Tattersfield A, Holgate S
Br J Clin Pharmacol
. 2004 Dec;
58(7):S751-5.
PMID: 15595965
No abstract available.
7.
8.
Johnson S, Whale C, Hubbard R, Lewis S, Tattersfield A
Thorax
. 2004 Aug;
59(9):800-3.
PMID: 15333859
Background: Lymphangioleiomyomatosis (LAM) is a rare and progressive disease of young women with no effective treatment. Previous estimates of 10 year survival, based mostly on case series or patients from...
9.
Harrison T, Oborne J, Newton S, Tattersfield A
Lancet
. 2004 Jan;
363(9405):271-5.
PMID: 14751699
Background: Asthma self-management plans that include doubling the dose of inhaled corticosteroid when the condition deteriorates improve asthma control. Whether doubling the dose of corticosteroid in isolation is effective is...
10.
Phillips K, Oborne J, Lewis S, Harrison T, Tattersfield A
Thorax
. 2003 Dec;
59(1):26-30.
PMID: 14694242
Background: It is important to be able to compare the efficacy and systemic effects of inhaled corticosteroids but their slow onset of action makes it difficult to measure the maximum...